Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Filip Geurs"'
Publikováno v:
Case Reports in Hepatology, Vol 2012 (2012)
Two patients are presented with severe jaundice, due to inoperable cholangiocarcinoma. The chemotherapeutic approach in patients with severe jaundice is discussed. Many schedules of chemotherapy were developed in this tumor type with normal serum bil
Externí odkaz:
https://doaj.org/article/02082d22c8874411ad98a70796b6a180
Autor:
Donna Holloway, Filip Geurs, Michelle Fan, Pirow Bekker, Thierry Facon, Mark C. Peterson, Jean-Jacques Body, Allan Lipton, Robert E. Coleman
Publikováno v:
Clinical Cancer Research. 12:1221-1228
PURPOSE: Receptor activator of nuclear factor-kappaB ligand (RANKL) is essential for the differentiation, function, and survival of osteoclasts, which play a key role in establishment and propagation of skeletal disease in patients with multiple myel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83929313ccd8825427467b10be33e6c0
https://doi.org/10.1158/1078-0432.ccr-05-1933
https://doi.org/10.1158/1078-0432.ccr-05-1933
Autor:
Steven W. Martin, Allan Lipton, Pirow Bekker, Jean-Jacques Body, Philip Greipp, Xavier Mariette, Filip Geurs, Jean-Paul Fermand, Arline Nakanishi, Jean-Luc Harousseau, Catherine D. Williams, Colin R. Dunstan, Donna Holloway, Thierry Facon, Robert E. Coleman
Publikováno v:
Cancer. 97:887-892
BACKGROUND Osteoprotegerin (OPG) is a decoy receptor for OPG ligand (OPGL), or receptor activator of NF-κB ligand (RANKL). RANKL/RANK interaction is important in terminal differentiation and activation of osteoclasts. In binding to RANKL, OPG blocks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119167ce7f793634d67bbfe8ea9f7e97
https://doi.org/10.1002/cncr.11138
https://doi.org/10.1002/cncr.11138
Autor:
Erna Van Droogenbroeck, Jacques Gielen, Mark Desmet, Johan Menten, Hans Wildiers, Filip Geurs, Peter Demeulenaere, Paul Clement, Chris Dhaenekint, Rita Van Nuffelen, Jean-Pierre Lobelle
Publikováno v:
Journal of pain and symptom management
Death rattle is a frequent symptom (25%-50%) in the terminal stage of life, but there is neither standardized treatment nor prospective investigation performed on the effectiveness of anticholinergic drugs. The aim of the present study was to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdfdbab6583c31e38b3fb34fd515eae
https://pubmed.ncbi.nlm.nih.gov/19875269
https://pubmed.ncbi.nlm.nih.gov/19875269
Publikováno v:
Clinical Lymphoma and Myeloma. 9:E33
Full Abstract Introduction A recent phase I report drew attention to the effectiveness of metronomic (daily low-dose oral) CPA and I.V. vinblastine in refractory Hodgkin disease. 1 We used this combination in a patient with Hodgkin lymphoma and exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c8791fe23e0e78330cce8e08c0135ef
https://doi.org/10.3816/clm.2009.n.095
https://doi.org/10.3816/clm.2009.n.095